Urinary L-FABP may lose its specificity for renal disease in early diabetic nephropathy, non-diabetic chronic kidney disease, polycystic kidney disease and idiopathic focal glomerulosclerosis, when liver disease is also present. This evidence concerns the gene FABP1 and chronic kidney disease.